Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Heterogeneity of severe asthma in Europe: a SHARP-er view.

The Lancet. Respiratory medicine·2026
Same author

[Documentation of biological treatment in asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Enhanced BDNF in Asthma: Does It Overrule Depression?

The journal of allergy and clinical immunology. In practice·2026
Same author

[Clinical and economic role of FeNO measurements in adults with asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Clinical phenotyping improves choices of biologics in asthma.

Lancet (London, England)·2026

Related Experiment Video

Updated: Jul 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

Asthma therapy concepts through the ages.

Marek Lommatzsch1

  • 1Department of Pneumology, Rostock University Medical Centre, University of Rostock, Rostock, Germany.

Allergologie Select
|January 22, 2024
PubMed
Summary
This summary is machine-generated.

New asthma treatments, including inhaled steroids and biologics, shift focus from symptom control to prevention and remission. Achieving asthma remission requires personalized treatment plans based on precise patient phenotyping and biomarker analysis.

Keywords:
DMAADsasthmaremissionsymptom prevention

More Related Videos

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.5K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K

Related Experiment Videos

Last Updated: Jul 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.5K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K

Area of Science:

  • Pulmonology
  • Allergology
  • Pharmacology

Background:

  • Asthma therapy has evolved from symptom management to a preventative approach.
  • Disease-modifying anti-asthmatic drugs (DMAADs), biologics, and immunotherapies are key advancements.
  • The concept of asthma remission is now a primary treatment goal.

Purpose of the Study:

  • To define asthma remission and its types.
  • To introduce a treat-to-target strategy for achieving asthma remission.
  • To highlight the importance of precise patient phenotyping for effective asthma management.

Main Methods:

  • Classification of asthma remission into spontaneous, off-treatment, and on-treatment.
  • Application of a treat-to-target approach, similar to other chronic inflammatory diseases.
  • Emphasis on comprehensive patient phenotyping: history, lung function, allergy testing, and type 2 biomarkers.

Main Results:

  • Asthma remission is characterized by sustained symptom absence, no exacerbations, and stable lung function without systemic steroids.
  • Successful achievement of asthma remission is possible through tailored, targeted therapies.
  • Individualized treatment necessitates detailed diagnostic assessments.

Conclusions:

  • Modern asthma management aims for remission using DMAADs, biologics, and immunotherapies.
  • A treat-to-target strategy guides personalized treatment for achieving remission.
  • Precise phenotyping and biomarker analysis are crucial for optimizing asthma remission strategies.